Bajaj Finserv Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ez3fcqbt43ez3pe1pepvhoc7.pdf

Key Takeaways


General Insurance: The Claims Correction

Sahni: "at this stage, maybe it will be very difficult to predict, because if both of these work in the direction as we feel - early reporting starts and people start getting more rational about commercials - then maybe going back to, levels of 97% - 98% may not be a big challenge."
Sreenivasan: "If you look at our ULR triangles, it's pretty clear that our original ULR is about 7.5% higher than our revised ultimate loss ratios. So, overall, these are some hidden things if you want to compare this to another company internationally. If you adjust for these, ROE will probably be closer to 20%, I presume."

Life Insurance: Volume Over Margin

Kalsi: "We always said that we look at NBV growth rather than the margin growth. And we have a very strong growth of NBV of 53%. Margin is a factor of multiple things."
Chugh: "the abnormal growth that we had because of high ticket is something which the sector should not really be expecting any further."

Lending: Steady Delivery on Guidance


The Ecosystem Build-Out

Sreenivasan: "So, it is not an investing holding company, that we put in financial markets and carry huge amount of surplus. It's a company where we continue to invest in the ecosystem of our customers, which today is largely middle class, mass affluent and above."

Distribution & Partnerships


Guidance & Commitments

CommitmentSpecificsTimeline
AMC product launchFirst suite of mutual fund productsQ2 FY24
BALIC high-ticket mix normalization₹5 lakh+ ticket share to revert to 8-9% range from 24% spikeOngoing from Q1 FY24
BAGIC motor OD loss ratioLong-term expected at 65-67%Long-term (no quarter given)
BAGIC motor TP loss ratio70-75% if Motor Vehicle Act early reporting materializesConditional on regulatory outcome
BAGIC health loss ratioRetail health loss ratios to start tapering down year-on-yearOver FY24
BAGIC health tariff hikeNext round of rate hikes expectedSometime during FY24 or toward year-end
BALIC group protectionIntends to expand and wrestle market share backAfter clarity on EoM guidelines
Bajaj Finserv Health investmentEqual investment to the ₹450 crores already deployedOver next 3-4 years

Key Metrics

MetricQ4 FY23
Consolidated total income₹23,625 cr, up 25% YoY
Consolidated profit after tax₹1,769 cr, up 31% YoY
Consolidated PAT (excl. MTM impact)up 28% YoY; MTM loss of ₹328 cr in FY23 vs gain of ₹2 cr in FY22
BAGIC gross domestic premium income growth14%; 16.4% excl. tender-driven businesses
BAGIC combined ratio97.3% for Q4; 100.5% for full year
BAGIC loss ratio66.4% vs 68.8% in Q4 FY22
BAGIC profit after tax₹322 cr, up 30% YoY
BAGIC AUM₹27,809 cr, up 13% YoY
BAGIC solvency ratio319%
BALIC individual rated new business premium growth48% vs industry 24% and private players 35%
BALIC new business value (net of expense overrun)₹415 cr, up 35% YoY; FY23 NBV ₹950 cr, up 53%
BALIC IRNB market share among private players7.6%, up from 6.7% in FY23
BALIC 13-month persistency83%
BALIC solvency ratio516%
BFL profit after tax₹3,158 cr, up 30% YoY
BFL gross NPA0.94% vs 1.6% last year
BFL net NPA0.34% vs 0.68% last year
BFL total AUM₹2,47,379 cr vs ₹1,92,087 cr as of 31 Mar 2022
BFL new loans booked75.6 Lakhs, up 20% YoY
BHFL AUM₹69,228 cr, up 30% YoY
BHFL profit after tax₹407 cr, up 52% YoY
Bajaj Finserv Direct total revenue (FY23)₹391 cr, up 89% YoY
Bajaj Finserv Direct lending disbursement₹1,313 cr vs ₹1,175 cr in Q3 FY23
Bajaj Finserv Health paying users9.67 Lakhs in Q4
Bajaj Finserv Health gross premium recorded for BAGIC (FY23)₹82 cr